What one share of Bionano Genomics holds
We are a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (“OGM”) solutions, nucleic acid extraction and purification systems, diagnostic services and software.
Bionano Genomics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.17 |
|---|---|
| Profit | −$3.38 |
| Cash and investments | $0.32 |
| Book value | $2.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $1,017 | −$1,568 | $28.12 | −$1,719 | — | $604.91 |
| 2019 | $405.78 | −$1,194 | $2.45 | −$1,185 | — | — |
| 2020 | $48.94 | −$236.58 | $0.00 | −$220.51 | — | $110.81 |
| 2021 | $38.98 | −$157.02 | — | — | — | $698.44 |
| 2022 | $57.68 | −$275.09 | — | — | — | $503.53 |
| 2023 | $63.47 | −$408.60 | — | — | — | $126.10 |
| 2024 | $24.21 | −$88.13 | — | — | — | $18.96 |
| 2025 | $5.24 | −$4.85 | — | — | — | $4.14 |
Common questions about Bionano Genomics
How much does one share of Bionano Genomics earn?
Over the last 12 months, Bionano Genomics lost $3.38 for each share on $3.17 of sales.
Does Bionano Genomics pay a dividend?
Bionano Genomics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Bionano Genomics’s book value per share?
Bionano Genomics’s book value is $2.68 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Bionano Genomics have?
Each share of Bionano Genomics has $0.32 of cash and investments, as of June 30, 2026.
Has Bionano Genomics bought back shares?
Bionano Genomics’s share count rose about 46063% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.